You are here: Industry Insights > Emerging Market

News List

Insights into Marketing New Drugs in Developed Markets: A Guide for Emerging Market Players David Orchard-Webb
November 02, 2023
In this guide, we will explore some valuable insights into marketing new drugs in developed markets, focusing on the needs and expectations of emerging market players.
High-value molecules going off-patent – from an emerging markets perspective Dr. Preet Pal S.B.
August 31, 2021
These are high perspective 10 small molecules that mid-cap manufacturers in emerging markets can consider adding to their product portfolio.
Biocon enters Dow Jones Sustainability Emerging Markets Index expresspharma
December 02, 2021
The company made a formal submission for Corporate Sustainability Assessment for its listing on DJSI for the first time this year and made it to the DJSI EM Index with a total Sustainability Score of 45 as against an industry average of 18, achieving...
COVAXX commits to deliver 140 million COVID-19 vaccine doses to emerging markets europeanpharmaceuticalreview
November 30, 2020
The company suggests their experimental COVID-19 vaccine, UB-612, has the features and potential to disrupt the traditional vaccine distribution and supply status quo.
Glenmark Pharma secures its position in Dow Jones Sustainability Emerging Markets Index expresspharma
November 27, 2020
Over 800 companies across sectors from the emerging markets were assessed, out of which 100 made it to the prestigious index this year including 11 from India.
ConvaTec sharpens focus on Asia Pacific and emerging markets prnasia
March 02, 2020
ConvaTec Group Plc is putting the Asia Pacific region, along with Latin America, The Middle East and Africa, at the forefront of its new operating model by establishing a fully integrated business unit called the Global Emerging Markets (GEM), according t
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets prnasia
August 06, 2019
Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today announced that ...
Alvotech, Cipla Gulf to commercialise key biosimilar in few emerging markets biospectrumasia
July 29, 2019
For the commercialization of AVT02, an adalimumab biosimilar, in select emerging markets.
Takeda mulling sale of emerging market drugs – report pharmaphorum
January 23, 2019
Takeda could be considering selling some emerging-market drugs in a bid to cut debts following its merger with Shire that completed earlier this month, according to a press report.
Emerging markets drugs worth $3B could be next on Takeda’s chopping board: report fiercepharma
January 22, 2019
Looking to trade in some assets outside Japan to fund its $58 billion takeover of Shire, Takeda is reportedly eyeing a sale of some emerging-market drugs it gained in another acquisition eight years ago.